DE69812887T2 - Mikropartikel aus chitosan-gelatin a - Google Patents

Mikropartikel aus chitosan-gelatin a

Info

Publication number
DE69812887T2
DE69812887T2 DE69812887T DE69812887T DE69812887T2 DE 69812887 T2 DE69812887 T2 DE 69812887T2 DE 69812887 T DE69812887 T DE 69812887T DE 69812887 T DE69812887 T DE 69812887T DE 69812887 T2 DE69812887 T2 DE 69812887T2
Authority
DE
Germany
Prior art keywords
bioadhesive
chitosan
microspheres
chitosan gelatin
polymeric material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69812887T
Other languages
English (en)
Other versions
DE69812887D1 (de
Inventor
James Watts
Lisbeth Illum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Services Ltd
Original Assignee
West Pharmaceutical Services Drug Delivery and Clinical Research Center Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by West Pharmaceutical Services Drug Delivery and Clinical Research Center Ltd filed Critical West Pharmaceutical Services Drug Delivery and Clinical Research Center Ltd
Publication of DE69812887D1 publication Critical patent/DE69812887D1/de
Application granted granted Critical
Publication of DE69812887T2 publication Critical patent/DE69812887T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
DE69812887T 1997-01-14 1998-01-14 Mikropartikel aus chitosan-gelatin a Expired - Lifetime DE69812887T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9700624.1A GB9700624D0 (en) 1997-01-14 1997-01-14 Drug delivery composition
PCT/GB1998/000108 WO1998030207A1 (en) 1997-01-14 1998-01-14 Chitosan-gelatin a microparticles

Publications (2)

Publication Number Publication Date
DE69812887D1 DE69812887D1 (de) 2003-05-08
DE69812887T2 true DE69812887T2 (de) 2003-12-18

Family

ID=10805925

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69812887T Expired - Lifetime DE69812887T2 (de) 1997-01-14 1998-01-14 Mikropartikel aus chitosan-gelatin a

Country Status (15)

Country Link
US (1) US6465626B1 (de)
EP (1) EP0952822B1 (de)
JP (1) JP2001508061A (de)
AT (1) ATE235889T1 (de)
AU (1) AU725460B2 (de)
CA (1) CA2275717C (de)
DE (1) DE69812887T2 (de)
DK (1) DK0952822T3 (de)
ES (1) ES2200306T3 (de)
GB (2) GB9700624D0 (de)
NO (1) NO993195L (de)
NZ (1) NZ335815A (de)
PT (1) PT952822E (de)
WO (1) WO1998030207A1 (de)
ZA (1) ZA98273B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008059857A1 (de) * 2008-12-01 2010-06-02 Forschungsinstitut für Leder und Kunststoffbahnen gGmbH Mit Kohlenhydrat-Derivaten additivierte Gelatinezusammensetzungen

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
EP1067910B1 (de) * 1998-04-03 2004-05-26 Egalet A/S Zusammensetzung mit kontrollierter wirkstoff-freisetzung
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
WO2000004876A2 (en) * 1998-07-23 2000-02-03 Johns Hopkins University School Of Medicine Controlled release of bioactive substances
US6916490B1 (en) 1998-07-23 2005-07-12 UAB Research Center Controlled release of bioactive substances
DE59908471D1 (de) * 1999-07-02 2004-03-11 Cognis Iberia Sl Mikrokapseln - II
GB9924797D0 (en) * 1999-10-20 1999-12-22 West Pharm Serv Drug Res Ltd Compound
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
GB0008411D0 (en) * 2000-04-05 2000-05-24 Vectura Ltd Pharmaceutical preparations and their manufacture
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
EP2263654B1 (de) * 2000-06-21 2012-10-10 Cubist Pharmaceuticals, Inc. Arzneizusammensetzungen zum Verbessern der oralen Absorption von antimikrobiellen Wirkstoffen
US7527807B2 (en) * 2000-06-21 2009-05-05 Cubist Pharmaceuticals, Inc. Compositions and methods for increasing the oral absorption of antimicrobials
IT1318618B1 (it) * 2000-07-10 2003-08-27 A C R Applied Coating Res S A Microsfere bioadesive a rilascio rapido per la somministrazionesublinguale di principi attivi.
ITMI20010347A1 (it) 2001-02-21 2002-08-21 Grisotech S A Complessi di immunoglobuline e polisaccaridi per assorbimento orale etrans-mucosale
US6777000B2 (en) 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
ATE375786T1 (de) 2001-08-16 2007-11-15 Cmp Therapeutics Ltd Chitin-mikropartikel und ihre medizinische verwendung
WO2003041723A1 (de) * 2001-11-12 2003-05-22 Reinmueller Johannes Pharmazeutische anwendungen von hyaluronsäure-präparaten
SI1458360T1 (sl) 2001-12-19 2011-08-31 Novartis Ag Pulmonalno dajanje aminoglikozidov
US6830556B2 (en) 2002-01-08 2004-12-14 Zimmer Orthopaedic Surgical Products, Inc. Debridement extension providing irrigation and mechanical scrubbing for removal of dead, devitalized, or contaminated tissue from a wound
US20040266026A1 (en) * 2002-01-10 2004-12-30 Amiji Mansoor M. Hybrid immobilized catalytic system with controlled permeability
WO2004073729A1 (ja) 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
USRE45404E1 (en) 2003-03-27 2015-03-03 Shin Nippon Biomedical Laboratories, Ltd. Powder medicine applicator for nasal cavity
CN1780555A (zh) * 2003-05-01 2006-05-31 韦斯特制药服务药物输送和临床研究中心有限公司 Lh－rh类似物亮丙瑞林的鼻部给药
US20050123588A1 (en) * 2003-06-16 2005-06-09 Zhu Yong H. Deployable multifunctional hemostatic agent
CN100381110C (zh) * 2003-06-16 2008-04-16 洛马林达大学医学中心 可展开的止血剂
EP1643934A4 (de) * 2003-06-16 2008-05-28 Univ Loma Linda Med Ablegbares hämostatisches mittel
GB0315632D0 (en) 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
DE10332160A1 (de) * 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
GB0328186D0 (en) 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
GB0329918D0 (en) 2003-12-24 2004-01-28 West Pharm Serv Drug Res Ltd Intranasal compositions
US20050175679A1 (en) * 2004-02-10 2005-08-11 Michael Moshman Controlled release formulations
JP4694214B2 (ja) * 2004-02-20 2011-06-08 ローム株式会社 比較器、ａｄ変換回路、半導体装置、および撮像装置
EP1718147B1 (de) 2004-02-23 2012-03-28 Loma Linda University Medical Center Hämostyptikum zur topischen und inneren anwendung
JP2007530537A (ja) * 2004-03-23 2007-11-01 リートン エンタープライズ，インコーポレーテッド キトサンを含有又は内包するカプセル
US7740883B2 (en) * 2004-03-28 2010-06-22 University Of Debrecen Nanoparticles from chitosan
US20050281886A1 (en) * 2004-05-06 2005-12-22 Ivrea Pharmaceuticals, Inc. Particles for the delivery of active agents
US20090204104A1 (en) * 2004-05-13 2009-08-13 Medtronic Vascular, Inc Methods for Compounding and Delivering a Therapeutic Agent to the Adventitia of a Vessel
GB0416328D0 (en) * 2004-07-21 2004-08-25 Univ Cardiff Use of dry powder compositions for pulmonary delivery
JP4922762B2 (ja) 2004-08-10 2012-04-25 株式会社新日本科学 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
DE102004059792A1 (de) 2004-12-10 2006-06-14 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Nukleinsäure-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
WO2006064331A1 (en) * 2004-12-17 2006-06-22 Medipol Sa Hydrophilic particles based on cationic chitosan derivatives
US20090136505A1 (en) * 2005-02-23 2009-05-28 Johanna Bentz Intranasal Administration of Active Agents to the Central Nervous System
US9539410B2 (en) 2005-04-19 2017-01-10 Abbott Cardiovascular Systems Inc. Methods and compositions for treating post-cardial infarction damage
US20080125745A1 (en) 2005-04-19 2008-05-29 Shubhayu Basu Methods and compositions for treating post-cardial infarction damage
US8303972B2 (en) * 2005-04-19 2012-11-06 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
NZ563271A (en) * 2005-04-29 2009-12-24 Cubist Pharm Inc Therapeutic compositions
JP2007006849A (ja) * 2005-07-04 2007-01-18 Japan Science & Technology Agency ６−アミノ−６−デオキシキトサン誘導体から成る核酸導入剤
NZ571965A (en) * 2006-03-30 2012-02-24 Engene Inc Chitosan-based nanoparticles and methods for transfecting gut cells in vivo
AU2007257436B2 (en) 2006-06-02 2013-05-02 Synedgen, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
AU2007262845B2 (en) 2006-06-20 2013-07-25 Mucovax Inc. Compositions comprising chitin microparticles and their medical uses
US20080248508A1 (en) * 2006-08-17 2008-10-09 Shenda Baker Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials
US9242005B1 (en) 2006-08-21 2016-01-26 Abbott Cardiovascular Systems Inc. Pro-healing agent formulation compositions, methods and treatments
US8741326B2 (en) * 2006-11-17 2014-06-03 Abbott Cardiovascular Systems Inc. Modified two-component gelation systems, methods of use and methods of manufacture
US9005672B2 (en) 2006-11-17 2015-04-14 Abbott Cardiovascular Systems Inc. Methods of modifying myocardial infarction expansion
US8337817B2 (en) 2006-12-26 2012-12-25 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
WO2008091588A1 (en) 2007-01-22 2008-07-31 Targacept, Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
GB0716907D0 (en) 2007-08-31 2007-10-10 Archimedes Dev Ltd Pharmaceutical powder compositions
GB0722507D0 (en) * 2007-11-19 2007-12-27 Zhao Xiaobin Hyaluronic acid personal lubricant
WO2010131486A1 (en) 2009-05-15 2010-11-18 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
WO2011013003A2 (en) 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
US8623274B2 (en) 2009-11-25 2014-01-07 Loma Linda University Medical Center Chitosan-based hemostatic textile
GB201006218D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
EP2696846B1 (de) * 2011-04-11 2018-01-17 Vitux Group AS Orale pharmazeutische dispersionszusammensetzungen
US8968790B2 (en) * 2011-12-09 2015-03-03 Shaker A. Mousa Nanoformulation of vitamin D derivatives and/or vitamin D metabolites
FR2991172A1 (fr) * 2012-06-01 2013-12-06 Galderma Res & Dev Compositions pharmaceutiques topiques comprenant des microcapsules
US9878000B2 (en) 2012-06-20 2018-01-30 University Of Waterloo Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
KR102177557B1 (ko) 2012-06-20 2020-11-11 유니버시티 오브 워터루 점막접착성 나노입자의 전달 시스템
US9259357B2 (en) 2014-04-16 2016-02-16 Loma Linda University Composition, preparation, and use of chitosan shards for biomedical applications
US10182993B2 (en) 2015-04-06 2019-01-22 Patheon Softgels Inc. Compositions for colonic delivery of drugs
CA3045043A1 (en) 2016-12-31 2018-07-05 Bioxcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
CN111712233A (zh) * 2018-02-26 2020-09-25 株式会社新日本科学 粉末制剂、药筒及装置
JP2021529756A (ja) 2018-06-27 2021-11-04 バイオエクセル セラピューティクス，インコーポレイテッド デクスメデトミジンを含むフィルム製剤、及びその作製方法
AU2020316013A1 (en) 2019-07-19 2022-02-17 Arx, Llc Non-sedating dexmedetomidine treatment regimens
CN112370437B (zh) * 2020-10-20 2022-10-21 好医生药业集团有限公司 一种阿莫西林胶囊及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226849A (en) 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
JPS6034925B2 (ja) 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
CA1219201A (en) 1983-03-07 1987-03-17 Albert E. Chu Microorganism detection test
GB8712176D0 (en) 1987-05-22 1987-06-24 Cosmas Damian Ltd Drug delivery system
GB8723846D0 (en) 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
CA2004270A1 (en) 1988-12-29 1990-06-29 William R. Michael Perfume microcapsules for use in granular detergent compositions
GB8904370D0 (en) 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
BE1003677A3 (nl) 1990-01-29 1992-05-19 Schacht Etienne Werkwijze voor het bereiden van azobevattende polymeren en het gebruik ervan als geneesmiddelafgiftesystemen.
EP0454444A1 (de) 1990-04-24 1991-10-30 Nissan Chemical Industries Ltd. Glutarimidderivate und Herbizide
CA2042529C (en) * 1990-08-10 2002-07-30 Chokyun Rha Polysaccharide article and uses therefor
IT1243390B (it) 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
GB9414966D0 (en) * 1994-07-26 1994-09-14 Danbiosyst Uk Pharmaceutical compositions for the nasal administration of antiviral agents
GB9416884D0 (en) 1994-08-20 1994-10-12 Danbiosyst Uk Drug delivery compositions
GB9419979D0 (en) 1994-10-04 1994-11-16 Medeva Holdings Bv Vaccine compositions
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008059857A1 (de) * 2008-12-01 2010-06-02 Forschungsinstitut für Leder und Kunststoffbahnen gGmbH Mit Kohlenhydrat-Derivaten additivierte Gelatinezusammensetzungen

Also Published As

Publication number Publication date
ATE235889T1 (de) 2003-04-15
AU5568998A (en) 1998-08-03
DE69812887D1 (de) 2003-05-08
NZ335815A (en) 2001-03-30
GB2335357B (en) 2000-12-13
AU725460B2 (en) 2000-10-12
NO993195D0 (no) 1999-06-28
ZA98273B (en) 1999-07-13
JP2001508061A (ja) 2001-06-19
GB2335357A (en) 1999-09-22
EP0952822A1 (de) 1999-11-03
CA2275717C (en) 2007-09-11
DK0952822T3 (da) 2003-07-21
CA2275717A1 (en) 1998-07-16
WO1998030207A1 (en) 1998-07-16
GB9700624D0 (en) 1997-03-05
NO993195L (no) 1999-06-28
GB9916018D0 (en) 1999-09-08
EP0952822B1 (de) 2003-04-02
ES2200306T3 (es) 2004-03-01
US6465626B1 (en) 2002-10-15
PT952822E (pt) 2003-08-29

Similar Documents

Publication Publication Date Title
DE69812887T2 (de) Mikropartikel aus chitosan-gelatin a
GB2305606A (en) Drug delivery composition for the nasal administration of antiviral agents
DE69028710T2 (de) Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung
ATE245450T1 (de) Haftende mikrokügelchen umfassende zusammensetzung zur arzneimittelgabe
DE69710757D1 (de) Milnacipranhaltige darreichungsform mit verzögerter wirkstoffabgabe
AR022930A2 (es) MICROCAPSULAS, DE TIPO RESERVORIO, QUE CONTIENEN POR LO MENOS UN PRINCIPIO ACTIVO MEDICAMENTOSO Y/O NUTRITIVO (PA) CON EXCLUSION DEL ACIDO ACETILSALICILICO (ASA), DESTINADAS A LA ADMINISTRACION POR VIA ORAL, SU UTILIZACIoN Y FORMA FARMACEUTICA QUE COMPRENDE A DICHAS MICROCAPSULAS.
HUP9904174A2 (hu) Bőrön át történő adagoláshoz szánt gyógyszerkészítmények
DE69803940T2 (de) Ophthalmische zusammensetzungen mit verlängerte freisetzung enthaltend im wasser lösliche arzneistoffe
EP0871435A4 (de) Drei verschiedene polymertypen enthaltende formulierung mit verzögerter freigabe
DE69326350D1 (de) Pharmazeutische formulierung
IL114193A0 (en) Ophthalmic pharmaceutical compositions
HU76547A2 (en) Process for producing pharmaceutical compositions containing agent in polymer-matrix and in solid solution form and these medicaments
WO2003103637A3 (en) MODIFIED RELEASE MULTIPLE UNIT DRUG DELIVERY SYSTEMS
SE9704401D0 (sv) Matrix pellets for greasy, oily or sticky drug substances
ES2071889T3 (es) Medicamento oral y agente de recubrimiento, que contiene un polisaccarido que se descompone en el colon.
WO2003053413A3 (en) Sustained-release compositions
WO1996040074A3 (en) Device for releasing aggregation-stabilized, biologically active agent
EP0571671A1 (de) Pulverförmige pharmazeutische Zusammensetzung
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
ES2164566A1 (es) Preparacion cosmetica o dermofarmaceutica compuesta de milicapsulas conrecubrimiento de polisacaridos cationicos.
HUP9902681A2 (hu) Térhálósított amilózt és hidroxi-propil-metil-cellulózt tartalmazó hordozóval készült szabályozott felszabadulású tabletta gyógyszerkészítmény
TH27939B (th) สูตรส่วนผสมทางเภสัช

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ARCHIMEDES DEVELOPMENT LTD., NOTTINGHAM, GB

8328 Change in the person/name/address of the agent

Representative=s name: STROHSCHAENK UND KOLLEGEN, 85521 OTTOBRUNN